Cargando…
Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma
Treatment of rectal cancer has been vastly improved by advances in surgery and radiochemotherapy but remains an important cause of morbidity and mortality worldwide. A particular problem is the lack of predictive markers that can help to individualize treatment. The growth- and apoptosis-regulating...
Autores principales: | Holck, Susanne, Klarskov, Louise Laurberg, Larsson, Lars-Inge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422203/ https://www.ncbi.nlm.nih.gov/pubmed/30899445 http://dx.doi.org/10.18632/oncotarget.26741 |
Ejemplares similares
-
Phospho-ERK1/2 levels in cancer cell nuclei predict responsiveness to radiochemotherapy of rectal adenocarcinoma
por: Holck, Susanne, et al.
Publicado: (2015) -
Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X
por: Haraldsson, Stefan, et al.
Publicado: (2017) -
Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy
por: Davies, Janine M, et al.
Publicado: (2011) -
Severe ulcerative oesophagitis caused by primary Epstein-Barr virus infection in an immunocompetent individual
por: Lorentsen, Ruben Due, et al.
Publicado: (2021) -
Heterogenous mismatch-repair status in colorectal cancer
por: Joost, Patrick, et al.
Publicado: (2014)